1. Introduction
===============

Medicinal plants are an important source of natural compounds with biological properties, including antimicrobial effects. Due to the occurrence of resistance to antimicrobials and the incidence of infectious diseases, there is a need to search for new antimicrobial compounds that may inhibit microorganisms by different mechanisms than those in current use \[[@B1-molecules-14-01171],[@B2-molecules-14-01171]\].

*Piper ovatum* Vahl (Piperaceae), an herbaceous plant occurring throughout Brazil, is popularly known as "joão burandi" or "anesthetic." It is used in traditional medicine for the treatment of inflammations and as an analgesic \[[@B3-molecules-14-01171]\]. The genus *Piper* includes about 700 species, which are widely distributed in tropical and subtropical regions. Because they contain some substances with biological activity, several species of *Piper* have been studied, and the presence of amides, lignanes, neolignanes, flavonoids, phenolic, terpenes and steroid compounds has been reported \[[@B4-molecules-14-01171],[@B5-molecules-14-01171]\].

An amide isolated from *Piper* species was piperine, which possesses analgesic and anti-inflammatory activity \[[@B6-molecules-14-01171]\]. Antimicrobial properties have also been reported for other *Piper* species: *P. lanceafolium* showed antifungal activity against *Candida albicans*, and extracts of *P. regnellii* showed antibacterial and antifungal activity \[[@B7-molecules-14-01171],[@B8-molecules-14-01171]\].

Piperovatine was isolated from the leaves of *P. alatabaccum* \[[@B9-molecules-14-01171]\]. Piperlongumine, piperovatine, isopiperlonguminine, corcovadine and isocorcovadine were obtained from *Ottonia frutens.* Piperovatine is also present in other species, such as *Ottonia frutescens* roots and bark, *P. piscatorum* roots, and *P. longum* fruits \[[@B10-molecules-14-01171],[@B11-molecules-14-01171]\]. Piperovatine and piperlonguminine from *P. ovatum* leaves showed excellent activity against amastigote and promastigote forms of *L. amazonensis*, and the mixture of these two amides showed an anti-inflammatory effect in an ear model in mice compared with the indomethacin control \[[@B12-molecules-14-01171],[@B13-molecules-14-01171]\].

Antifungal activity of essential oils extracted from *Piper aduncum, Piper arboreum* and *Piper tuberculatum* leaves, bark and fruits against *Cladosporium sphaerospermum* and *Cladosporium cladosporioides* has been reported \[[@B14-molecules-14-01171]\]. *P. multiplinervium* showed an antimicrobial effect against *Helicobacter pylori, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Mycobacterium smegmatis, Pseudomonas aeruginosa* and *Candida albicans* \[[@B15-molecules-14-01171]\]. 35 compounds have been identified by CG and CG-MS analysis of *Ambrosia trifida* oil, which showed antimicrobial activity against bacteria and fungi \[[@B16-molecules-14-01171]\].

*Candida* species are harmLess saprophyte yeasts, components of the normal human biota in the gastrointestinal tract and oral and vaginal mucosae. These yeasts can cause superficial infections such as thrush and vaginitis; however, if the immune defenses of the host become compromised, they can cause severe systemic infections. Although *C. albicans* is the most common fungal pathogen, infections associated with non-*albicans* species have been increasing. *Candida tropicalis* is the third most common species isolated \[[@B17-molecules-14-01171],[@B18-molecules-14-01171]\].

Studies of plants as a source of therapeutic agents should be emphasized. In the present study, we identified active substances and essential oil compounds obtained from *Piper ovatum* Vahl, and investigated their antimicrobial activity *in vitro.*

2. Results and Discussion
=========================

Active fractions obtained from leaves of *Piper ovatum* were identified as piperovatine (**1**) and piperlonguminine (**2**) by analyses of their ^1^H- and ^13^C-NMR data of and comparison with data from the literature \[[@B13-molecules-14-01171],[@B19-molecules-14-01171]\]. [Figure 1](#molecules-14-01171-f001){ref-type="fig"} shows the chromatogram of the crude extracts. Peak 1, with a retention time of 23.50 min, was identified as piperovatine. Peak 2, with a retention time of 24.46 min, was piperlonguminine. For component identification, the essential oil was submitted to Gas Chromatography and Mass Spectrometry (GC/MS) analysis, and the substances identified are listed in [Table 1](#molecules-14-01171-t001){ref-type="table"}. The components isolated in the highest quantities were *δ*-amorphene (16.5 %), *cis*-muurola-4(14),5-diene (14.29 %) and γ-muurolene (13.26%). The oil obtained from *P. ovatum* was found to be composed of approximately equal amounts of monoterpene hydrocarbons (6.82%), oxygenated monoterpenes (2.27%), oxygenated sesquiterpene (27.27%), sesquiterpene hydrocarbons (52.27%), ketones (4.54%) and unidentified compounds (6.82%).

![Chromatograms of hydroalcoholic extracts of stems (A), leaves (B) and root (C) *Piper ovatum*; where the piperovatine (1), piperlonguminine (2). Chromatographic conditions: Metasil ODS column; mobile phase: acetonitrile:water 0 % of acetonitrile for 60 % in 30 minute and acetonitrile:water 60:40 (v/v) in isocratic for 10 minute, with 1% acetic acid; ﬂow rate: 1.0mL/min; room temperature; detection: 280 nm.](molecules-14-01171-g001){#molecules-14-01171-f001}

molecules-14-01171-t001_Table 1

###### 

Main components of the essential oil from the aerial parts of *P. ovatum* Vahl.

  Peak No.   Components                       Área(%)   IK     IK\*   Identification Method
  ---------- -------------------------------- --------- ------ ------ -----------------------
  1          *α*-Pinene                       0.27      930    939    RT GC MS
  2          *β*-Pinene                       0.38      1020   1024   RT GC MS
  3          Sylvestrene                      0.45      1024   1030   RT GC MS
  4          Terpinyl acetate                 0.21      1334   1349   RT GC MS
  5          Silphiperfol-4,7(14)-diene       2.34      1348   1360   RT GC MS
  6          *α*-Copaene                      4.55      1376   1376   RT GC MS
  7          *α*-Dihydroionone                0.14      1384   1412   RT GC MS
  8          Longifolene                      0.24      1390   1407   RT GC MS
  9          *β*-Elemene                      0.46      1392   1390   RT GC MS
  10         (E)-Caryophyllene                8.49      1419   1419   RT GC MS
  11         *β*-Gurjunene                    1.76      1428   1433   RT GC MS
  12         (E)- *α*-Ionone                  0.19      1433   1430   RT GC MS
  13         Aromadendrene                    0.22      1436   1441   RT GC MS
  14         *cis*-Calamenene                 1.64      1448   1529   RT GC MS
  15         *α*-Humulene                     0.41      1450   1460   RT GC MS
  16         Allo-Aromadendrene               0.33      1459   1460   RT GC MS
  17         NI                               1.46      1470          
  18         γ- Muurolene                     16.50     1476   1479   RT GC MS
  19         *cis*-Muurola-4(14),5-diene      14.29     1478   1466   RT GC MS
  20         γ-Gurjunene                      0.39      1481   1477   RT GC MS
  21         *trans*-Muurola-4(14),5-diene    1.15      1485   1493   RT GC MS
  22         *δ*- Cadinene                    4.89      1489   1523   RT GC MS
  23         *α*-Muurolene                    3.04      1494   1500   RT GC MS
  24         *γ*-Cadinene                     6.01      1508   1513   RT GC MS
  25         *δ*-Amorphene                    13.26     1518   1511   RT GC MS
  26         *trans*-Cadina-1,4-diene         1.40      1525   1534   RT GC MS
  27         *α*-Cadinene                     0.49      1530   1538   RT GC MS
  28         *α*-Calacorene                   0.28      1535   1545   RT GC MS
  29         Selina-3,7(11)-diene             0.37      1548   1546   RT GC MS
  30         *trans*-Dauca-4(11),7-diene      0.26      1559   1557   RT GC MS
  31         N.I.                             0.38      1575          
  32         *β*-Copaen-4*α*-ol               0.72      1579   1590   RT GC MS
  33         Guaiol                           0.20      1582   1600   RT GC MS
  34         1,10-di- *epi*-Cubenol           0.33      1593   1619   RT GC MS
  35         *γ*-Eudesmol                     0.36      1608   1632   RT GC MS
  36         *cis*-Cadin-4-en-7-ol            1.73      1620   1636   RT GC MS
  37         N.I.                             0.32      1624          
  38         *epi*- *α*-Muurolol              2.77      1635   1642   RT GC MS
  39         *α*-Muurolol                     1.03      1639   1646   RT GC MS
  40         *α*-Eudesmol                     0.38      1644   1653   RT GC MS
  41         *α*-Cadinol                      2.03      1647   1654   RT GC MS
  42         Bulnesol                         0.24      1663   1671   RT GC MS
  43         10-nor-Calamenen-10-one          0.71      1677   1702   RT GC MS
  44         7,14-anhydro-Amorpha-4,9-diene   0.77      1738   1756   RT GC MS

T= Retention time; MS = mass spectra; GC=Gas Chromatography; KI- was calculated from the GC-MS chromatograms, Ki\*-calculated using Adams data \[[@B20-molecules-14-01171]\].

Extracts from leaves, bark and roots of *Piper ovatum* were active against *B. subtilis* (250, 500 and 250 µg/mL, respectively) and *C. tropicalis* ATCC 28707 (500, 250 and 62.5 µg/mL, respectively) ([Table 2](#molecules-14-01171-t002){ref-type="table"}). The isolated substances piperovatine and piperlonguminine showed good activity, with MIC values of 15.6 and 31.2 µg/mL, respectively, towards *B. subtilis* and of 3.9 µg/mL (both) towards *C. tropicalis* ATCC 28707. Piperlonguminine exhibited more activity then piperovatine against urine clinical isolates of *C. tropicalis*, with MIC 31.25 µg/mL ([Table 2](#molecules-14-01171-t002){ref-type="table"}). Essential oil extracted from *P. ovatum* leaves showed an effect against *C. tropicalis* ATCC 28707 and *C. tropicalis* from urine clinical isolates (22.6±3.1 and 18.7 ±2.1 mm respectively, [Table 3](#molecules-14-01171-t003){ref-type="table"}). Reduction of optical density at 530 nm and 495 nm indicated growth inhibition of *B. subtilis* and *C. tropicalis* at the tested concentrations from 0 to 125 µg/mL of piperovatine and piperlonguminine ([Figure 2](#molecules-14-01171-f002){ref-type="fig"}). Both piperovatine and piperlonguminine showed an effect on the adherence of *C. tropicalis* on cover glasses. When compared to untreated control yeasts, a decrease in the intensity of adhesion occurred in yeast treated with 10 µg/mL of the isolate ([Figure 3](#molecules-14-01171-f003){ref-type="fig"}).

molecules-14-01171-t002_Table 2

###### 

Minimal inhibitory concentration of *Piper ovatum* Vahl extracts and amides (µg/mL) and antibiotics used as a positive control.

  Microrganisms       Origin             root     bark     leaves   1        2        Flu    Tetra
  ------------------- ------------------ -------- -------- -------- -------- -------- ------ -------
  *E. coli*           ATCC 25922         \>1000   \>1000   \>1000   \>1000   \>1000          1
  *P. aeruginosa*     ATCC 27853         \>1000   \>1000   \>1000   \>1000   \>1000          12.5
  *E. cloacae*        ATCC 13047         \>1000   \>1000   \>1000   \>1000   \>1000          12.8
  *B. subtilis*       ATCC 6623          250      500      250      15.6     31.2            2.68
  *S. aureus*         ATCC 25923         \>1000   \>1000   \>1000   \>1000   \>1000          0.95
  *S. epidermidis*    ATCC *12228*       \>1000   \>1000   \>1000   \>1000   \>1000          1.9
  *C. tropicalis*     ATCC 28707         62.5     250      500      3.9      3.9      1.9    
  *C. albicans*       ATCC 10231         \>1000   \>1000   \>1000   \>1000   \>1000   7.8    
  *C. parapsilosis*   ATCC 22019         \>1000   \>1000   \>1000   \>1000   \>1000   1.9    
  *C. glabrata*       Urine              \>1000   \>1000   \>1000   \>1000   \>1000   31.2   
  *C. krusei*         Urine              \>1000   \>1000   \>1000   \>1000   \>1000   62.5   
  *C. tropicalis*     catheter tip                                  \>1000   \>1000   3.9    
  *C. tropicalis*     Urine                                         250      250      3.9    
  *C. tropicalis*     orotracheal tube                              \>1000   \>1000   3.9    
  *C. tropicalis*     Urine                                         500      500      3.9    
  *C. tropicalis*     Urine                                         250      125      3.9    
  *C. tropicalis*     Urine                                         125      62.5     3.9    
  *C. tropicalis*     Urine                                         125      31.25    3.9    
  *C. tropicalis*     Urine                                         250      250      3.9    

**1** (piperovatine); **2** (piperlonguminine); oil (essential oil); Flu (fluconazole) and Tetra (tetracycline)

molecules-14-01171-t003_Table 3

###### 

Antifungical activity (inhibition zone expressed in mm) investigated *Piper ovatum* Vahl essential oils and antibiotic used as a positive control.

  Microrganisms     Origin             *Pure essential oil*   Nystatin
  ----------------- ------------------ ---------------------- -----------
  *C. tropicalis*   ATCC 28707         22.6±3.1               32 ± 2.7
  *C. tropicalis*   catheter tip       14.3±1.1               27 ± 0.8
  *C. tropicalis*   Urine              18.7 ±2.1              30 ± 0.3
  *C. tropicalis*   orotracheal tube   13.8 ±0.8              23 ± 0.7
  *C. tropicalis*   Urine              16.0 ±1.0              25 ± 1.3
  *C. tropicalis*   Urine              11.9 ±1.1              35 ± 0.42
  *C. tropicalis*   Urine              10.0±1.0               34 ±1.2
  *C. tropicalis*   Urine              12.8 ±1.7              32 ± 2.1
  *C. tropicalis*   Urine              14.0 ±0.7              26 ±0.7

The values represent the average of three determinations ± standard deviations

![Growth inhibition of *Bacillus subtilis* ATCC 6623 and *C. tropicalis* ATCC 28707, by reduction on optical density at 530 nm and 495 nm, respectively.](molecules-14-01171-g002){#molecules-14-01171-f002}

The effect on the morphology of *C. tropicalis* treated with amides extracted from *P. ovatum* was investigated by scanning electron microscopy. The MIC values for piperovatine were 15.2 and 3.9 µg/mL for *B. subtilis* and *C. tropicalis* respectively, and the values for piperlonguminine were 31.2 and 3.9 µg/mL, indicating a selective toxicity to these microorganisms. Many studies have been conducted on antimicrobial activity, including screenings of plants in search of antimicrobial properties \[[@B8-molecules-14-01171]\]. Here we describe the isolation of active agents from *Piper ovatum* Vahl (Piperaceae) with antimicrobial effects.

![Adherence inhibition assay. A and C) *C. tropicalis* treated with 10 µg/mL of pipeovatine and piperlonguminine, respectively. B and D) *C. tropicalis* without treatment (control). Bars = 50µm.](molecules-14-01171-g003){#molecules-14-01171-f003}

In the analysis of the essential oil of *P. aduncum*, a total of 46 components were identified. The major component was identified as dill apiole or 4,5-dimethoxy-6-(2-propenyl)-1,3-benzodioxole (43.3 %), together with other minor components such as β-caryophyllene (8.3 %), piperitione (6.7 %) and α-humulene (5.1 %). Essential oil derived from *P. gibbilimbum* is dominated by the gibbilimbols A-D (74.2 %), with the remaining constituents being the terpenes camphene (13.6 %) and α-pinene (6.5 %) \[[@B20-molecules-14-01171]\]. Data from the present study showed that the hydroalcoholic extract and the amides piperovatine and piperlonguminine from *P. ovatum* Vahl have good antimicrobial activity against *B. subtilis* and *C. tropicalis*. Essential oil was inhibitory to *C. tropicalis*. There is also an effect on adherence of *C. tropicalis* on glass, and low toxic effects to cells.

3. Conclusions
==============

This report describes the isolation of the amides piperovatine and piperlonguminine, and the analysis of the chemical composition of essential oil obtained from *P. ovatum* leaves. Of the 41 compounds identified, those present in the largest quantities were *δ*-amorphene (16.5 %), *cis*-muurola-4(14),5-diene (14.29 %) and γ-muurolene (13.26%). Antimicrobial activity was observed against *B. subtilis,* and *C. tropicalis*, including clinical strains*.* Although there was a selective toxicity to fungal and bacterial cells, showing that this plant oil, extracts and pure compounds may have commercial potential as an antiseptic agent, further studies are necessary to elucidate the mechanism of antimicrobial action.

4. Experimental
===============

4.1. Plant material
-------------------

Leaves of *Piper ovatum* Vahl were collected in December 2006 in Monte Formoso, state of Minas Gerais, Brazil, and were identified by Dr. Elsie Franklin Guimarães. A voucher specimen was deposited in the herbarium of the Department of Botany, University of Maringá (HUM 10.621).

4.2. Plant extraction and purification
--------------------------------------

Leaves were dried at room temperature and powdered (100 g). The extract was prepared by exhaustive maceration in ethanol-water (9:1 v/v) at room temperature, filtration, concentration under vacuum at 40°C to obtain a hydroalcoholic extract, and then lyophilization, which yielded 25 g of extract. The hydroalcoholic extract (14 g) was chromatographed in a vacuum silica-gel column, and eluted with gradients of hexane, dichloromethane-ethyl acetate (1:1 v/v), ethyl acetate and methanol, affording F1 (2.09 g), F2 (3.93 g), F3 (2.61 g) and F4 (3.70 g). The dichloromethane-ethyl acetate fraction F2 (3.93 g) was rechromatographed on a silica gel 60 (70-230 mesh) column chromatograph eluted with gradients of hexane, hexane/CH~2~Cl~2~ (98:2, 95:5, 90:10, 80:20 and 50:50 v/v), CH~2~Cl~2~, CH~2~Cl~2~/EtOAc (98:2, 95:5, 90:10, 80:20 and 50:50 v/v), EtOAc and MeOH, affording 108 fractions. Subfractions 23-38 (258.2 mg) were identified as mixtures of piperovatine and piperlonguminine. These subfractions were rechromatographed on a Sephadex LH 20, and the column chromatograph was eluted with ethyl acetate, obtaining 55 fractions. Fractions 13-30 (15 mg) and 39-48 (35 mg) were isolated and identified as piperovatine (**1**) and piperlonguminine (**2**) respectively, by analyses of ^1^H- and ^13^C --NMR data and comparison with data from the literature \[[@B13-molecules-14-01171],[@B19-molecules-14-01171]\]. The NMR spectra were obtained on Bruker DRX-400 (8.4 T) and Varian Gemini 300 (7.05 T) spectrometers, using the deuterated solvent (CDCl~3~) TMS as the internal standard and a constant temperature of 298 K. Low-resolution electrospray data were acquired in the negative ion mode, using a Micromass Quattro-LC instrument. Silica gel 60 (70-230 and 230-400 mesh); TLC: silica gel plates F~254~ (0.25 mm thickness) were used for chromatographic separations.

4.3. Leaves distillation
------------------------

*Piper ovatum* leaves (100 g) were hydrodistilled in a Clevenger-type apparatus for 3 h. The oil layers obtained were dried over anhydrous Na~2~SO~4~. The yields (2.3 % w/w) were averaged over three experiments, and calculated on the basis of the dry weight of the material. For GC studies, 1 mg of oil dissolved in 1.5 mL of hexane and 1 µL of solution was injected into the GC-MS spectrometer.

4.4. GC/MS analysis
-------------------

For component identification, the essential oils were submitted to Gas Chromatography and Mass Spectrometry (GC/MS) analysis, performed using an Agilent GC (6890 Series) -- quadrupole MS system (5973), equipped with a fused silica capillary column (30 m x 0.25 mm i.d. x 0.25 µm film, coated with DB-5), EI operating at 70 eV. Injector and detector temperatures were set at 250^o^C. The oven temperature program was 40°C for 1 min and 40- 240 °C at 3 °C/min, and helium was employed as the carrier gas (1 mL/min). The compound was identified by comparing retention indices \[Kóvats Index (KI), determined relative to the retention times of a series of *n*-alkanes\] \[[@B21-molecules-14-01171]\] and mass spectra with literature data \[[@B22-molecules-14-01171]\].

4.5. HPLC analysis
------------------

The HPLC analyses were carried out using a GILSON apparatus equipped with a quaternary pump (Pump 321), automatic injector valve (234) with 20 µL loop, degasifier (865), CTO-10Avp oven and a UV/visible detector model 152, controlled by a BOWTER computer program. In the chromatographic analysis, we used a reverse-phase column Metasil ODS, 5 µm, 150.0 x 4.6 mm, kept in an oven set at ambient temperature. HPLC conditions were as follows: solvent A, acetonitrile, and solvent B, 1.0 % acetic acid. A gradient elution used was 0--30 min, 0-60% A; 30--40 min, 60% A. Flow rate was 1.0 mL/min, and detection was at 280 nm. All the samples were prepared in triplicate. The reagents used to prepare the mobile phase were acetonitrile (HPLC grade from OmniSolv EM Science, Gibbstown, NJ), ultrapure water (Milli-Q system, Millipore, Bedford, USA), acetic acid (analytical grade, Merck, Darmstadt, Germany), and methanol (HPLC grade from OmniSolv EM Science, Gibbstown, NJ). The stock solutions of extracts of the leaves, stems and roots from *P. ovatum* were prepared in methanol at a concentration of 1,000 µg/mL. The solutions were filtered through a 0.45 µm membrane filter (Millipore, São Paulo, Brazil).

4.6. Strains and growth conditions
----------------------------------

The test microorganisms used included *Escherichia coli* ATCC 25922, *Pseudomonas aeruginosa* ATCC 27853, *Enterobacter cloaceae* ATCC 13047, *Bacillus subtilis* ATCC 6623, *Staphylococcus aureus* ATCC 25923, *Staphylococcus epidermidis* ATCC 12228, *Candida albicans* ATCC 10231, *C. tropicalis* ATCC 28707, *C. parapsilosis* ATCC 22019, and two clinical isolates of *C. glabrata* and *C. tropicalis* and one of *C*. *krusei*. Bacteria were maintained on Mueller Hinton Agar and subcultured in Mueller Hinton Broth before each experiment. Yeasts were maintained at 4 °C on Sabouraud Dextrose Agar plates and subcultured at 37 °C in Sabouraud Dextrose Broth before each experiment, to ensure viability and purity.

4.7. Microdilution MIC determination
------------------------------------

The minimal inhibitory concentrations of the extract and oil for the strains were determined according to the M27-A2 and M7-A7 broth microdilution reference procedure of the NCCLS \[[@B23-molecules-14-01171]\]. RPMI 1640 medium with L-glutamine without bicarbonate buffered with 0.165 M MOPS (morpholine propanesulfonic acid) was used for yeasts, and Mueller-Hinton broth for bacteria. Serial two-fold dilutions of the extracts and isolated substances were done in a microdilution plate (96 wells) containing 100 µL of sterile medium. Next, the inoculum was added to each well. The microplates were incubated at 37 °C for 48 h for yeasts and 24 h for bacteria. The MIC was defined as the lowest concentration that resulted in inhibition of visual growth. Minimal microbicidal concentrations were determined by subculturing 10 µL of the culture from each negative well and from the positive control, measured as described.

4.8. Adherence inhibition assay
-------------------------------

*C. tropicalis* (10^6^ CFU/mL) suspension, untreated (control) and treated with decimal dilutions of piperovatine and piperlonguminine (1,000 to 0.1 µg/mL) were aliquoted (500 µL) onto a 24-well plate containing round cover glasses. The plate was incubated at 37 °C for 1 h. The cover glasses were washed with sterile phosphate buffer saline (PBS) and observed with an inverted microscope.

4.9. Scanning electron microscopy
---------------------------------

Yeasts treated with piperovatine and piperlonguminine (3.9 µg/mL) were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2. Small drops of the fixed cells were placed on a specimen support with poly-L-lysine for 1 hour at room temperature. Subsequently, the samples were dehydrated in graded ethanol, critical-point dried in CO~2~, coated with gold, and examined on a Shimadzu SS-550 scanning electron microscope. Yeasts without treatment were also prepared.

4.10. Cytotoxicity assay
------------------------

To investigate the cytotoxic effects of extract and isolated substances, confluent Vero and macrophage J774G8 cell monolayers grown in 96-well cell culture plates were incubated with different concentrations of extract, piperovatine and piperlonguminine for 48 h at 37 °C and 5% CO~2~. At the time, cultures fixed with 10% trichloroacetic acid for 1 h at 4 °C were stained for 30 min with 0.4% Sulforhodamine B (SRB) in 1% acetic acid and subsequently washed with distilled water. Bound SRB was solubilized with 150 µL 10 mM Tris-base solution. Absorbance was read in an ELISA plate reader at 530 nm. The cytotoxicity was expressed as a percentage of the optical density compared to the control.

4.11. Disc diffusion method
---------------------------

*In vitro* antifungal activity of the *P. ovatum* essential oil was determined by the agar disk diffusion method according to Rubio *et al.* \[[@B24-molecules-14-01171]\]. Briefly, a suspension of each tested microorganism (2.0 mL of 10^5^ cells per mL) was carefully mixed in a tube with Mueller Hinton Agar (MHA, 18 mL), and then poured on Petri plates. Sterile filter-paper discs (Whatman No. 1, 6.0 mm in diameter) were impregnated with 15 µL of the oil and placed on the inoculated plates. Control disks containing 15 µL of the physiological saline and nystatin (100 U.I. or 20 µg/disc, Cecon, São Paulo, Brazil) were used. These plates were allowed to dry at room temperature for 2 h, and were incubated at 25ºC for 48 h. The diameters of the inhibition zones were measured in millimeters, and their means were calculated. All the tests were performed in triplicate, and the strains were tested, as listed in [Table 3](#molecules-14-01171-t003){ref-type="table"}.
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